Supplement Shows Promise in Blocking Amyloid in Alzheimer’s

Your incompetent? doctor and hospital won't get human testing going, will they?

All this earlier research which I bet your doctor/hospital knows nothing!

arginine (2 posts to December 2016)

arginine-rich peptides (1 post to February 2015)

Cationic arginine-rich peptides (1 post to March 2020)

poly-arginine peptides (1 post to February 2015)

Do you prefer your doctor and hospital incompetence NOT KNOWING? OR NOT DOING?

Supplement Shows Promise in Blocking Amyloid in Alzheimer’s

Summary: A new study shows that oral arginine, a naturally occurring amino acid, can significantly suppress amyloid-β aggregation in Alzheimer’s disease models. Researchers found that arginine not only prevented Aβ42 from clumping but also reduced plaques and inflammation in mouse and fruit fly models carrying Alzheimer’s-related mutations.

Treated mice showed improved cognitive performance alongside reduced neuroinflammation, indicating broad neuroprotective effects. Because arginine is clinically safe, affordable, and widely available, it holds strong potential as a repurposed therapeutic strategy pending further human studies.

Key Facts:

• Aggregation Blocker: Arginine reduced Aβ42 aggregation in vitro and in Alzheimer’s disease models.
• Neuroprotective Effects: Treatment lowered plaques, decreased inflammatory markers, and improved behavior.
• Clinical Potential: Arginine’s safety and low cost make it a promising candidate for rapid therapeutic repurposing.

Source: Kindai University

Alzheimer’s disease (AD), a progressive neurodegenerative disorder, is one of the leading causes of dementia worldwide, and currently has no definitive cure. Although antibody-based therapies that target amyloid β (Aβ) have recently been developed, their clinical effectiveness remains limited.